The aim of this study was to evaluate the in vitro characteristics of [177Lu]Lu-DOTA-C595 across pancreatic cancer cell lines with different expression of MUC1-CE to establish its feasibility as RIT for PDAC. Here, MUC1 is linked to pancreatic neoplasm.